The medical device industry continues to experience rapid growth, driven by technological innovation, regulatory advancements, and increasing global healthcare demand. This panel brings together active investors to discuss the latest trends, opportunities, and challenges in the medical device industry.

Topics addressed may include:

• Emerging technologies and current trends that excite investors
• Investment strategies and due diligence process on medical device opportunities
• Navigating regulatory hurdles and barriers to market entry
• Case studies of successful medical device investments

This panel will be an insightful discussion on how investors capitalize on this dynamic sector while driving advancements in patient care and medical technology.

As global markets become increasingly interconnected, cross-border investments between US, Europe, and beyond are unlocking new opportunities for growth. This panel brings together experienced investors, legal experts, and industry leaders to explore the complexities of international investments and strategies for navigating regulatory, economic, and geopolitical challenges.

Topics addressed may include:

• The importance of fostering cross-border investment and partnership opportunities in the life sciences & healthcare industry
• Strategies for mitigating risks and optimizing cross-border deal structures
• How current economic trends are shaping international investment flows
• Examples of successful cross-border deals

This panel will be an in-depth discussion on how investors can successfully expand their portfolios, how companies can better seek to work with these global investors, leverage international opportunities, and navigate the evolving global investment landscape.

Many large corporations establish corporate venture or innovation arms to invest and partner with life science and healthcare companies. However, every corporate venture capital firm has a unique approach and strategy in investment, and their ties to the corporation can differ. Some invest only in areas that complement the parent company’s existing interest areas, while some may source for opportunities beyond those interest areas. This panel will uncover insights from active corporate VC firms and how they seek to drive innovation, accelerate R&D, and bring transformative solutions to market.

 Topics addressed may include:

• How CVCs align investments with corporate strategy in healthcare & life sciences
• Balancing financial returns with long-term patient and industry impact
• The role of CVCs in fostering biotech, medtech, and digital health innovation
• Due diligence & investment process – how can companies seek to work with these firms?

This panel will provide exclusive insights from active corporate VC investors on emerging investment trends, strategic priorities, and the evolving role of corporate venture capital in transforming healthcare.

The digital health landscape continues to expand rapidly, with a growing emphasis on disease-specific solutions beyond chronic disease management and mental & behavioral health. Reimbursement for digital health companies has been improving and accelerating – digital therapeutics, AI/ML-driven patient monitoring and diagnostics tools are all important technologies that have enormous potential in improving patient outcomes. This panel will bring together active digital health investors to talk about latest trends, opportunities, and challenges in the digital health sector.

Topics addressed may include:

• Emerging technologies and current trends that excite investors
• Investment strategies and due diligence process on digital health opportunities
• Navigating regulatory and reimbursement hurdles
• Examples of successful digital health investments

This panel will provide actionable insights into the evolving digital health investment landscape and its impact on the broader healthcare ecosystem.

Seed funding plays a pivotal role in translating scientific research into impactful healthcare solutions, providing crucial capital for early-stage product development, clinical trials, and regulatory preparations. This panel will bring together seed investors with expertise in various life science and healthcare sectors to discuss how they support startups through the initial stages of research, prototype development, and navigating regulatory pathways.

Topics addressed may include:

• The role of seed investors and the impact they have on the early-stage life sciences and healthcare ecosystem
• Strategies on due diligence and assessment in early-stage opportunities, especially on identifying ventures with high potential and navigating risk
• Particular areas of interest within life sciences and healthcare
• Approaches that funds take to help seed stage companies to scale and grow

Seed funds are important catalysts in fostering early stage innovations, and this panel will be an insightful panel on learning more from those that invest in the earliest stage opportunities.

With biotech VC investment in 2024 increasing over 33% compared to the previous year and robust in-licensing activity, this year brings more optimism to the biotech ecosystem. Many investors continue to partner with and invest in biotech companies across various modalities and indications, in hopes of accelerating novel, transformative therapeutics that can impact the lives of patients suffering from debilitating diseases.

Topics addressed may include:

• Emerging trends and therapeutic areas of interest, exciting breakthroughs in major indications
• The role of different types of investors and partners, including traditional VCs and in-licensing partners
• Considerations companies must have to navigate through R&D and properly scale, especially those with platform technologies with potential in multiple indications
• Investment and due diligence process – how do you derisk opportunities, especially when many biotech companies are in pre-clinical and early clinical stage?

Investment and strategic partnering in biotech plays a key role in accelerating therapies and addressing high unmet need. This panel will uncover insights from some of the key players who aim to make an impact by supporting transformative solutions to go to market.

Enabling tailored treatments to individual patients on genetic, environmental, and lifestyle factors, personalized and precision medicine are crucial in advancing higher quality of care and diagnosis. This panel will bring together active personalized medicine investors to share more insights about this space as well as future outlook in how technologies currently in development can disrupt the current standard of care and diagnosis, as well as helping patients better understand and manage their health.

Topics addressed may include:

• Current trends or particular technologies that are exciting to investors
• Current challenges, such as data integration and equitable access
• Overall investment and due diligence process
• Recent successful investments in personalized medicine

Advancements in personalized medicine and care can will continue to positively impact on quality of life and increasing healthy lifespans across the globe. This panel will be an insightful discussion on better understanding the current ecosystem.